Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015and further to our earlier intimation dated February 06, 2024 and September 04, 2025, we wish toinform you that post the successful validation of batches by our European partner, commercialproduction at Phase 1 of cGMP-4 plant at Dewas has commenced today.